arrow_back Civic Audit
Share share

US Support for Global Vaccines: Protecting Health and National Security

This House Resolution affirms continued US financial support for Gavi, the Vaccine Alliance, to save children's lives and combat infectious diseases globally. The resolution emphasizes that these investments are a critical component of US health security, reducing the risk of outbreaks reaching American soil. It encourages multiyear funding commitments to maximize Gavi's impact in low-income countries.
Key points
Continued US funding for Gavi to deliver essential vaccines (including malaria and Ebola) to low-income countries.
Enhancing US health security by stemming infectious disease outbreaks at their source globally.
Recognizing the high return on investment: $1 invested yields $54 in global health and economic savings.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HRES_848
Sponsor: Rep. Kean, Thomas H. [R-NJ-7]
Process start date: 2025-10-31
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Supporting the role of the United States in helping save the lives of children and protecting the health of people in low-income countries with vaccines and immunization through Gavi, the Vaccine Alliance ("Gavi").

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_848.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-10-31.

What are the main provisions?

Key points include:

  • Continued US funding for Gavi to deliver essential vaccines (including malaria and Ebola) to low-income countries.
  • Enhancing US health security by stemming infectious disease outbreaks at their source globally.
  • Recognizing the high return on investment: $1 invested yields $54 in global health and economic savings.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kean, Thomas H. [R-NJ-7].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Foreign Affairs.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Economy